このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

心臓病の女性に対する運動トレーニング 2 (EXCEED2)

2026年9月30日 更新者:Ottawa Heart Institute Research Corporation

心臓病の女性における運動トレーニング: ランダム化比較試験

This study will compare the effects of two different types of training on exercise capacity in women with coronary heart disease (CHD). Participants will be randomized into either the virtual high-intensity interval training (HIIT) or the virtual moderate-to-vigorous intensity continuous training (MICT). After randomization, patients will exercise twice a week, for 12 weeks. The sessions will be conducted virtually. Patients will undergo a maximal exercise test, cardiometabolic indicators (height (cm), body mass (kg), body composition (%), waist circumference (cm) and, resting blood pressure) and complete questionnaires about quality of life, mental health, self-determined motivation, self-efficacy and enjoyment.

調査の概要

状態

募集

介入・治療

詳細な説明

Heart disease is a leading cause of death for women. Women who suffer a heart attack are more likely than men to be inactive, have lower fitness, and die in the next year; patients also report poor mental health and quality of life (QoL), and have a greater risk of cardiovascular disease risk factors. This clinical research project is concerned about women with heart disease and how to improve their fitness, mental health, and QoL using a different kind of exercise. Currently, moderate-to-vigorous intensity continuous training, MICT, is the most frequently prescribed for women with heart disease. Unfortunately, this exercise tends to be a burden and is time-consuming. The study aims to test if high-intensity interval training (HIIT, alternating periods of hard exercise and rest) is better than MICT at improving fitness, mental health, QoL, and exercise dedication in women with heart disease. The investigators will recruit 104 women with heart disease. The investigators will first assess the health measures outlined above and then randomly assign people to MICT or HIIT. Both groups will attend virtual exercise sessions 2 days/week for 12 weeks. The MICT group will perform Zumba/movement-based exercise for 35 minutes at an intensity level of 70-85% of their maximal effort. The HIIT group will perform Zumba/movement-based exercise for 25-minutes: this will consist of 4 periods of exercising for 4-minutes at an intensity level of 85-95% of their maximal effort, separated by 3 minutes of rest between each period. The investigators will assess the health measures again after 12 and 26 weeks. The scores for people in the two groups will then be compared. HIIT has never been evaluated as an alternative for MICT in a large women-only group with heart disease. If this clinical trial shows that HIIT helps these women improve their physical and psychosocial health over usual practice, then health care professionals caring for women with heart disease will have an alternative, effective treatment option to provide women in need.

研究の種類

介入

入学 (推定)

172

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

    • Ontario
      • Ottawa、Ontario、カナダ、K1Y 4W7
        • 募集
        • University of Ottawa Heart Institute
        • コンタクト:
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

説明

Inclusion Criteria:

  1. Women (i.e., female sex assigned at birth) with CHD (e.g., coronary artery bypass grafting surgery [CABG], percutaneous coronary intervention [PCI], acute myocardial infarction [MI], MI with no obstructive coronary artery disease [MINOCA], or ischemia with no obstructive coronary artery disease [INOCA] at least 4 weeks post procedure or event; based on clinical evidence this is a safe period of time to exercise);
  2. Patient is able to perform a symptom limited CPET (this is the primary outcome and needed to determine peak HR for the exercise training prescription); and
  3. Patient is able to read and understand English or French.

Exclusion Criteria:

  1. Patient is currently participating in routine exercise training (>2x/week, routine exercise training is defined as a planned, structured, and repetitive exercise that is performed in order to maintain or improve physical fitness.) (this may reduce the impact of HIIT or MICT on outcomes);
  2. Patient has: NYHA class III-IV heart failure symptoms; unstable angina; or established diagnosis of chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy (this may interfere with the ability to engage in MICT or HIIT);
  3. Patient has uncontrolled arrhythmia (this may impact the HR-based exercise training prescription and monitoring);
  4. Patient is unable to provide written informed consent; or
  5. Patient is unwilling or unable to return for follow-up visits at 12 and 26 weeks.
  6. Patient is unwilling to be randomized to HIIT or MICT.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:standard care + moderate-intensity continuous exercise training

2 days/week Warm-up: 60-70% peak HR - 10min Training: 70-85% peak HR - 35min Cool-down: 60-70% peak HR - 15min

The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.

実験的:standard care + high-intensity interval training

2 days/week Warm-up: 60-70% peak HR - 10min Training: 85-95% peak HR - 25 minutes (4x4-minutes of high-intensity intervals interspersed with 3 minutes of low-intensity intervals) Cool-down: 60-70% peak HR - 10min

The MICT and HIIT intervention groups will complete supervised virtual exercise sessions for 12 weeks using Zoom care or Microsoft Teams as a backup resource. The appointments will be scheduled and conducted 2 days per week. Initially, exercise intensity will be determined from participants' peak HR achieved during a baseline CPET.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Exercise capacity
時間枠:from baseline to week-6 and from baseline to week-12

will be measured using a gold standard symptom-limited, cardiopulmonary exercise test (CPET) on a treadmill (or on an alternate equipment, such as a cycle ergometer or recumbent bike). Gas exchange will be monitored continuously (- Parvo Medics TrueOne® 2400); the highest 20 second average rate of oxygen uptake achieved (i.e. peak VO2 in mL/kg/min) during the last minute of the CPET will represent exercise capacity.

from baseline to week-6 and from baseline to week-12

二次結果の測定

結果測定
メジャーの説明
時間枠
physical and mental health
時間枠:from baseline to 12 weeks and baseline to 26 weeks

hysical and mental health will be measured using the Mental Health Composite Scale (MCS) and Physical Composite Scale (PCS) of the Short Form-36 questionnaire. It consists of 36 items that contribute to eight subscales summarized into a physical component summary scale (PCS) and a mental component summary scale (MCS). A higher score on a 0-100 scale indicates a better quality of life.

from baseline to 12 weeks and baseline to 26 weeks
Disease-specific Quality of Life, global health, physical and emotional health
時間枠:from baseline to 12 weeks and baseline to 26 weeks

measured using the HeartQoL, a validated 14-item questionnaire that assesses patients' feelings on how heart disease affects daily functioning, providing a global-health related QoL score and physical and emotional subscales. Higher score means better quality of life. Score range from 0-3, where higher scores represents better heart quality of life.

from baseline to 12 weeks and baseline to 26 weeks
Anxiety symptoms
時間枠:from baseline to 12 weeks and baseline to 26 weeks

assessed with the Generalized Anxiety Disorder-7 (GAD-7).Participants rate statements regarding symptoms of anxiety on a 4-point scale (0=not at all; 4=nearly every day). The items are summed to obtain a score ranging from 0-21.

from baseline to 12 weeks and baseline to 26 weeks
Depressive symptoms
時間枠:from baseline to 12 weeks and baseline to 26 weeks

Depressive symptoms: assessed with the Patient Health Questionnaire (PHQ-9), a 9-item scale based on diagnostic criteria for depressive disorders. Participants rate statements on a 4-point scale (0=not at all; 4=nearly every day), yielding a single score indicating severity of depression symptoms.

from baseline to 12 weeks and baseline to 26 weeks
body composition - BMI
時間枠:from baseline to 12 weeks and baseline to 26 weeks

body mass (kg) and height (cm) will be measured to calculate body mass index (kg/m^2)

from baseline to 12 weeks and baseline to 26 weeks
body composition - Waist circumference
時間枠:from baseline to 12 weeks and baseline to 26 weeks

Changes in body composition from baseline to 12 weeks and baseline to 26 weeks are measured by waist circumference (cm).

from baseline to 12 weeks and baseline to 26 weeks
body composition - BIA
時間枠:from baseline to 12 weeks and baseline to 26 weeks

Changes in body composition from baseline to 12 weeks and baseline to 26 weeks are measured by bioelectrical impedance (%)

from baseline to 12 weeks and baseline to 26 weeks
Vital Signs - Resting Blood Pressure
時間枠:from baseline to 12 weeks and baseline to 26 weeks

changes in vital signs will be measured using resting blood pressure (mmHg) in a seated position after a 5-minute rest period on the right arm using an automated monitor (BPTru) that measures 3 times at 2-minute intervals.

from baseline to 12 weeks and baseline to 26 weeks
Vital Signs - Resting Heart Rate
時間枠:from baseline to 12 weeks and baseline to 26 weeks

changes in vital signs will be measured using resting heart rate (bpm)

from baseline to 12 weeks and baseline to 26 weeks
Self-determined motivation for exercise
時間枠:from baseline to 12 weeks and baseline to 26 weeks

the 24-item Behavioural Regulation in Exercise questionnaire (BREQ-3) yields an overall Relative Autonomy Index (RAI) score, representing overall self-determined motivation. The scale ranges from -3 "amotivation to +3 "intrinsic regulation".

from baseline to 12 weeks and baseline to 26 weeks
Overall self-efficacy for exercise
時間枠:from baseline to 12 weeks and baseline to 26 weeks

the 9-item Multidimensional Self-Efficacy for Exercise Scale (MSES-R) yields an overall self-efficacy for exercise score reflecting scheduling, task and coping self-efficacy. The MSES consists of nine items on a 100% confidence scale ranging from 0 = "no confidence" to 100 = "completely confident."

from baseline to 12 weeks and baseline to 26 weeks
physical activity enjoyment
時間枠:from baseline to 12 weeks and baseline to 26 weeks

the 18-item Physical Activity Enjoyment Scale (PACES) measures the extent (on a 7-point Likert scale) to which participants enjoy doing physical activity. Overall enjoyment for physical activity score is determined by summing the items, with a range of 18-126 being possible. Higher scores indicate higher enjoyment.

from baseline to 12 weeks and baseline to 26 weeks
Gender
時間枠:from baseline to 12 weeks and baseline to 26 weeks

assessed using the Genesis-Praxy questionnaire.

from baseline to 12 weeks and baseline to 26 weeks

その他の成果指標

結果測定
メジャーの説明
時間枠
Physical activity levels
時間枠:from baseline to 12 weeks and baseline to 26 weeks

will be measured objectively. The ActiGraph wGT3X-BT accelerometer (ActiGraph, Pensacola, Florida) will be worn over the right hip for 7 days

from baseline to 12 weeks and baseline to 26 weeks
Program compliance
時間枠:from baseline to 12 weeks

Staff will record the number of MICT or HIIT sessions attended over the 12-week period (attended/prescribed x 100 = % compliance). Staff will record the number of MICT or HIIT sessions attended over the 14 weeks of unsupervised virtual exercise session.

Reasons for missing exercise sessions and program drop-out will be collected to inform the development of strategies to engage women in CR.

from baseline to 12 weeks
Participant Experience
時間枠:at 12 weeks

As per the ORBIT model166 for developing effective behavioural treatments for chronic diseases, semi-structured focus groups (N=4)167 with patients (N=20, purposively selected according to age, gender, and medical conditions)168 will be conducted at 12 weeks to explore factors influencing adherence and satisfaction with MICT or HIIT. Each focus group will be 60-90 minutes in duration and will be held at times convenient for the participants

at 12 weeks
Feeling Scale
時間枠:during intervention

To assess affective response during exercise, the Feeling Scale will be completed during and immediately post exercise. The patient will report the value in a one-on-one chat function. The FS is an 11-point, single-item, bipolar rating scale commonly used for the assessment of affective valence (i.e., please-displeasure) during exercise. The scale ranges from -5 ("Very Bad") to +5 ("Very Good").

during intervention
Participant Feedback
時間枠:from baseline to 12 weeks

To assess the participant's experience using a virtual intervention method.

from baseline to 12 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Jennifer Reed, PhD、Ottawa Heart Institute Research Corporation

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2025年1月27日

一次修了 (推定)

2028年12月31日

研究の完了 (推定)

2029年3月30日

試験登録日

最初に提出

2024年7月2日

QC基準を満たした最初の提出物

2024年7月2日

最初の投稿 (実際)

2024年7月10日

学習記録の更新

投稿された最後の更新 (実際)

2026年10月5日

QC基準を満たした最後の更新が送信されました

2026年9月30日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する